Register
Register
Register

Project cooperationUpdated on 26 September 2026

Pilot & Validation Partners: Digital Biomarkers, Workplace Resilience & Cognitive Health

Founder & CEO at Shellix Smart Solutions A.Ş.

Muğla, Türkiye

About

Shellix Smart Solutions A.Ş. invites research hospitals, clinical neuroscience departments, academic institutes, and enterprise employers to collaborate as pilot and clinical validation partners.

Partnership Scope:

1. Clinical & Academic Validation:

- Conducting randomized controlled trials (RCTs) or observational clinical studies evaluating non-pharmacological interventions for acute anxiety, insomnia, chronic workplace stress, and occupational fatigue.

- Investigating autonomic biomarkers (heart-rate variability, rPPG facial blood flow, quantitative EEG power spectra) in response to multimodal sensory stimulation.

2. Enterprise Workplace Wellbeing Pilots:

- Deploying Mistikist and Pulsate across knowledge-worker teams (IT, healthcare shift workers, finance, customer support) to measure impact on burnout rates, presenteeism, and subjective wellbeing.

- Seamless rollout via native Microsoft Teams and mobile devices with zero hardware procurement required.

3. Immersive Learning & Cognitive Performance:

- Validating BeyondLearn and Timeception in corporate training and university environments to optimize focus, learning retention, and executive performance under cognitive load.

What We Provide to Partners:

- Full access to Shellix software platforms and enterprise analytics dashboards.

- Co-authorship and scientific collaboration on high-impact peer-reviewed publications.

- Co-application for international research grants (Horizon Europe, TÜBİTAK 1071 / Bilateral Cooperation, EIT Health).

Stage

  • Ideation - identifying the project idea / Concept note/ Idea
  • Design - setting the project scope
  • Completing the consortia

Topic

  • Digital and Smart Health

Call

  • HORIZON-HLTH-2027-01-STAYHLTH-01: Addressing disabilities through the life course to support independent living and inclusion HO
  • HORIZON-HLTH-2027-02-DISEASE-14-two-stage: Clinical trials for advancing innovative interventions for neurodegenerative diseases
  • HORIZON-HLTH-2027-01-CARE-02: Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
  • HORIZON-HLTH-2027-02-TOOL-01-two-stage: Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases

Type

  • Partner seeks Consortium
  • Partner offers specific expertise / technical solution

Similar opportunities